Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative.

Haddad P, Shazadi S, Samiei F, Kharrazi HH, Tabatabaeefar M, Rakhsha A, Faranoosh M, Torabi-Nami M, Dadras A, Liaghi A, Nafarieh L.

Int J Clin Exp Med. 2015 Mar 15;8(3):3946-55. eCollection 2015.

2.

Adaptation of a quality of life questionnaire for Iranian patients with esophageal cancer.

Forootan M, Tabatabaeefar M, Maghsoodi N, Ardeshiri M, Fatemi M, Rahimzadeh H.

Indian J Palliat Care. 2014 May;20(2):123-7. doi: 10.4103/0973-1075.132629.

3.

Metabolic syndrome and colorectal cancer: a cross-sectional survey.

Forootan M, Tabatabaeefar M, Yahyaei M, Maghsoodi N.

Asian Pac J Cancer Prev. 2012;13(10):4999-5002.

4.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

5.

Incidence rate of ovarian cancer in Iran in comparison with developed countries.

Arab M, Khayamzadeh M, Tehranian A, Tabatabaeefar M, Hosseini M, Anbiaee R, Golfam F, Akbari ME.

Indian J Cancer. 2010 Jul-Sep;47(3):322-7. doi: 10.4103/0019-509X.64721.

6.

Crude and age-specific incidence rate patterns for histopathologic subtypes of ovarian cancer in Iran.

Arab M, Khayamzadeh M, Hashemi M, Hosseini M, Tabatabaeefar M, Anbiaee R, Anvari N, Ebrahimi M, Akbari ME.

Arch Iran Med. 2010 May;13(3):203-8.

7.

Survival of ovarian cancer in Iran: 2000-2004.

Arab M, Khayamzadeh M, Mohit M, Hosseini M, Anbiaee R, Tabatabaeefar M, Ebrahimi M, Tehranian A, Akbari ME.

Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):555-8.

Supplemental Content

Loading ...
Support Center